Similar articles

• The production of biotin by genetically modified micro-organisms.

  Brown SW, Kamogawa K. Brown SW, et al. Biotechnol Genet Eng Rev. 1991;9:295-326. Biotechnol Genet Eng Rev. 1991. PMID: 1797017 Review. No abstract available.
• Introduction: exploitation of conventional and industrial microorganisms.

  Murooka Y. Murooka Y. Bioprocess Technol. 1994;19:1-13. Bioprocess Technol. 1994. PMID: 7764752 Review. No abstract available.
• Genetically-engineered microorganisms: II. Survival multiplication and genetic transfer.

  Strauss HS, Hattis D, Page G, Harrison K, Vogel S, Caldart C. Strauss HS, et al. Recomb DNA Tech Bull. 1986 Jun;9(2):69-88. Recomb DNA Tech Bull. 1986. PMID: 3532217 No abstract available.
• Overexpression for commercial production of recombinant human insulin as A-chain and B-chain fusion protein in Escherichia coli through genetically engineered plasmids.

  Chakraborty C. Chakraborty C. Indian J Pathol Microbiol. 2004 Oct;47(4):569-73. Indian J Pathol Microbiol. 2004. PMID: 16295400
• [Topicalities from gene technology. Protein synthesized by bacteria the better therapeutic alternative (author's transl)].

  Hobom B, Hobom G. Hobom B, et al. MMW Munch Med Wochenschr. 1981 Sep 18;123(38):1423-6. MMW Munch Med Wochenschr. 1981. PMID: 6169986 German.